What Is Ibogaine, and What Is It Used For?

Key Takeaways

• Opioid and fentanyl withdrawal is the best-studied use of ibogaine, and small observational studies show large drops in withdrawal symptoms after a single dose.
• A 2024 Stanford study of 30 special operations veterans with TBI reported major improvements in disability, PTSD, depression, and anxiety one month after treatment.
• Evidence for alcohol, cocaine, and methamphetamine withdrawal, as well as treatment for chronic pain, is at an earlier stage and comes mostly from animal research and retrospective reports.
• The main safety risk is cardiac. Ibogaine and noribogaine slow how the heart resets after each beat, and that effect can last for days after a dose.
• Cardiologist screening, EKG monitoring, electrolyte checks, and magnesium supplementation are the core safeguards against cardiac complications.

Ibogaine is a natural psychoactive substance found in the African shrub Tabernanth Iboga. It has emerged as a promising alternative for the treatment of various addictions. In some treatment facilities, doctors use this compound to help patients overcome serious drug dependencies. While research is still ongoing, ibogaine has been shown to help interrupt addictive patterns and behaviors and reduce withdrawal symptoms. While still illegal in the United States, clinical research around the world continues to study its therapeutic value. If you’re considering ibogaine treatment, it’s important to understand what ibogaine does and the potential benefits of using ibogaine treatment.

Ibogaine is mainly used to interrupt opioid addiction and reduce withdrawal symptoms, and it’s also being studied for alcohol and stimulant addiction, and relief from post-traumatic stress disorder (PTSD), depression, and traumatic brain injury (TBI). It’s traditionally used in Bwiti ceremonies in Gabon, where the root bark of the Tabernanthe iboga shrub has been part of spiritual practice for generations. Ibogaine remains a Schedule I substance in the United States, although public funding for clinical trials has grown fast, including $50 million approved by Texas lawmakers in 2025. In Mexico, where Experience Ibogaine operates, it is unscheduled. Before you consider treatment, it helps to understand what ibogaine does, where the evidence is strong, where it’s still thin, and how the risks are managed.

What Is Ibogaine?

Ibogaine is a natural compound found in the root bark of the iboga plant, a shrub that is indigenous to Central and West Africa. French and Belgian expeditions first documented this powerful substance’s ceremonial use in the 19th century. Local communities, especially in Gabon, Cameroon, and Congo, used ibogaine regularly, and it played a vital role in the tradition and rituals of the Bwiti and Pygmy spiritual practices. It has gained attention for its potential in treating addiction, particularly to heroin and other opiates.

Over time, ibogaine has drawn attention from Western scientists as a promising treatment for drug addiction, especially opioid dependence, and disorders such as PTSD and brain trauma. European colonizers first documented this fascinating compound and brought it back to Europe, where it was initially used as a stimulant.

Ibogaine’s anti-addictive properties were first discovered in 1962 by Howard Lotsoft when he was 19 years old and a regular heroin user. He tried ibogaine for the first time and experienced a deep visionary state where he interacted with his earliest memories. Thirty hours later, when the effects subsided, he discovered that he no longer craved heroin or experienced any withdrawal symptoms. Reportedly, he then gave ibogaine to seven other addicts, five of whom stopped taking drugs immediately afterward.

Howard Lotsoft authored numerous research papers about ibogaine’s anti-addictive properties and was awarded patents for the treatment of various dependencies with ibogaine. In later years, ibogaine was declared a Schedule I substance in the United States. However, it continued gaining attention through anecdotal evidence, journalism, and scientific research.

Psychedelic Properties of Ibogaine

The psychedelic properties of ibogaine are very profound and distinct from other psychedelics like psilocybin or LSD. Ibogaine induces a unique altered state of consciousness characterized by vivid, dream-like visions and introspective experiences. Users often report a panoramic review of their lives where memories and past events are replayed and can be re-evaluated. This retrospective journey can be intensely therapeutic and allows individuals to gain new perspectives on their experiences, confront their trauma, and understand some of the underlying factors involved in their addiction. The components in psychedelic ibogaine also induce a strong dissociative state. Users often report a feeling of detachment from their physical body, which can contribute to their profound introspective state.

What Is Ibogaine Used For?

Ibogaine is best known for easing opioid withdrawal, yet clinics and researchers are beginning to use it for a wider range of substance use disorders and mental health conditions. The strength of the evidence varies a lot from one condition to the next. Each section below covers what’s known so far and how treatment at Experience Ibogaine works for that condition.

Opioid and Fentanyl Withdrawal

Opioids such as heroin and fentanyl artificially stimulate the brain’s mu-opioid receptors. Over time, the brain adapts by reducing the number of active receptors and making the remaining ones less sensitive to its own endorphins. Stopping suddenly leaves those receptors understimulated, and that gap is what drives the sweats, aches, nausea, and cravings of withdrawal. Ibogaine appears to interrupt this cycle and ease withdrawal within hours of a single dose.

The clearest human data comes from a 2018 New Zealand study of 14 patients. Withdrawal scores fell from 25.21 to 14.21 within 24 hours of treatment, and 12 of the 14 had stopped or reduced opioid use over the following year. Their drug-use scores on the Addiction Severity Index dropped by more than 80% at 12 months. The study was small and had no control group, so results like these are encouraging but not conclusive.

Fentanyl needs extra preparation. Because it’s stored in fat tissue, fentanyl is first flushed from the body with IV saline and ascorbic acid for about a week before ibogaine is given, and the full program usually runs around 12 days. Patients on methadone or Suboxone must switch to a short-acting opiate for one to three months before treatment, after which the program runs about five days. After the dose, expect a “gray day” of fatigue and residual withdrawal, which medication helps ease. Learn more about our opioid addiction treatment and fentanyl addiction treatment.

Alcohol Addiction

Most of the evidence for relief from alcohol addiction is preclinical. A 2005 study in The Journal of Neuroscience found that ibogaine reduced alcohol intake in rodents by raising levels of glial cell line-derived neurotrophic factor (GDNF), a protein that supports dopamine neurons. When researchers blocked GDNF, the effect disappeared. Human data is limited to retrospective reports and patients with mixed substance use, so controlled trials are still needed.

A medically managed alcohol detox still comes first, because alcohol withdrawal can cause seizures. Patients who arrive already detoxed typically stay about five days, whereas those who need on-site detox or liver support stay 12 days or longer. See our alcohol addiction treatment page for details.

Cocaine and Methamphetamine Addiction

Cocaine and methamphetamine sharply raise dopamine levels in the brain’s reward system. Their withdrawal is less physical than opioid withdrawal, but cravings and low mood can last for weeks. Ibogaine is thought to help by acting on dopamine and serotonin transporters and by giving patients a window of reduced craving.

A 2014 Brazilian study followed 75 patients who used alcohol, cannabis, cocaine, and crack, most of them more than one substance. Overall, 61% stayed abstinent after treatment, with a median of 5.5 months after a single session and 8.4 months after multiple sessions. The study was retrospective, but it’s one of the larger human datasets available. Read about our cocaine addiction treatment and methamphetamine addiction treatment.

PTSD

Ibogaine’s introspective state lets many patients revisit traumatic memories with less fear attached to them. In a 2024 Stanford study published in Nature Medicine, 30 special operations veterans received magnesium plus ibogaine, and PTSD symptoms fell by 88% one month later. Before treatment, 23 of the 30 met the criteria for PTSD.

Ibogaine can help significantly with PTSD. Lasting change, though, depends on therapy and integration after treatment, which is why our aftercare includes therapy sessions. Visit our PTSD treatment page to learn more.

Traumatic Brain Injury (TBI)

TBI was the main focus of the Stanford study. Participants’ disability scores on the World Health Organization Disability Assessment Schedule dropped from 30.2, a mild-to-moderate rating, to 5.1, which means no disability. Researchers also saw gains in concentration and memory. These effects are linked to neuroplasticity, the brain’s ability to form and reorganize neural connections. The study had no placebo group, so larger trials are underway. Find out more about our traumatic brain injury treatment.

Depression and Anxiety

Depression and anxiety often occur alongside addiction and trauma. In the same Stanford cohort, depression scores dropped by 87% and anxiety by 81% at the one-month mark. The New Zealand opioid study also recorded steady improvement in depression across its 12-month follow-up. Ibogaine is thought to affect serotonin and dopamine signaling, though the exact mechanism is still being studied. Our anxiety and depression treatment page explains how we approach these conditions.

Chronic Pain

Chronic pain relief has the least research behind it. Most patients who come to us for pain want to lower their opioid tolerance or stop pain medication altogether. Outcomes vary. Some find their pain is gone, others are referred to a pain management specialist, and some may need to resume medication for a while. We’ll talk through those possibilities with you before treatment. Our pain management treatment page has more detail.

How Does Ibogaine Treatment Work?

Ibogaine promotes neuroplasticity, resets the brain’s reward system, and interacts with neurotransmitters. These effects reduce withdrawal symptoms and provide patients with the opportunity to break free from trauma and substance use disorder and begin their sobriety journey.

Resetting the Brain’s Reward System

Ibogaine treatment is thought to interrupt patterns of substance use disorder by restoring a healthy dopamine level and reducing cravings. By resetting the brain’s reward system, it provides patients with a period of time to detox and establish new routines that help them maintain sobriety.

Promotion of Neuroplasticity

Traumatic brain injuries and substance use affect your brain’s neural pathways. Ibogaine can promote neuroplasticity, which may allow the brain to recover from injury or addiction. Ibogaine has shown potential for treating PTSD and substance use disorder, which may be partly due to improved neuroplasticity.

Reducing Withdrawal Symptoms

Withdrawal symptoms make it difficult for many people to detox from certain substances, especially opiates, and can trigger relapses. Ibogaine reduces withdrawal symptoms and eases the detox process. Unlike traditional detox methods, ibogaine interrupts an individual’s addiction cycle at its core. It resets the brain’s reward system and helps minimize cravings.

Benefits of Ibogaine Treatment

Ibogaine treatment has helped many patients change how their brain responds to substances and build long-term recovery. Unlike other traditional methods, it works at a deep level, targeting the emotional and physiological causes of substance use disorder.

Effective for Addiction Treatment

Ibogaine is known for its ability to interrupt the cycle of addiction. Whether you’re dependent on alcohol, opioids, or other substances, ibogaine helps you reset your brain’s chemistry. It reduces cravings and withdrawal from opioids, alcohol, and other substances and helps patients regain control over their lives.

Promotes Emotional Healing

Individuals dealing with addictions and mental health issues often have deep underlying trauma. Ibogaine treatment induces an introspective state that allows patients to confront their past experiences, reprocess traumatic experiences, and gain new perspectives on their lives. During this treatment, patients can gain powerful insights that help them release their past burdens and move forward.

Supports Mental Health

Ibogaine has shown promising results in alleviating mental health conditions such as depression and PTSD. Ibogaine supports mental health by interacting with neurotransmitters in the brain.

Is Ibogaine Safe? Risks and How They’re Managed

Ibogaine has gained recognition due to its ability to help patients overcome addiction. However, despite its promising effects, ibogaine treatment does come with some risks and side effects.

This treatment is not FDA-approved, and ibogaine remains a Schedule I substance in the United States, though it is unscheduled in Mexico. Nausea and dizziness are common during treatment, and many patients have trouble with balance for a day or so. The most serious risk involves the heart, which is why we monitor the effects so closely.

How Ibogaine Affects the Heart

Ibogaine and its main metabolite, noribogaine, block hERG potassium channels in heart cells. Those channels help the heart muscle reset, or repolarize, after every beat. When repolarization slows, an electrocardiogram (EKG) shows a longer QT interval, and a heart with a prolonged QT interval is more prone to dangerous rhythms such as torsades de pointes.

Timing is crucial. Your liver converts ibogaine into noribogaine, which lingers far longer than the parent drug. In a 2016 placebo-controlled study, noribogaine had a half-life of 24 to 30 hours, and QT prolongation rose in step with its blood levels. That delay explains why a share of the cardiac events and deaths reported in case literature happened days after a dose, long after the visionary phase had ended. Pre-existing heart disease, low potassium or magnesium, other QT-prolonging medications, and opioids or stimulants still in the system all raise the risk further.

How Experience Ibogaine Manages Cardiac Risk

Being upfront about this risk is part of how we earn your trust. Here’s how our medical team reduces it.

• Cardiologist evaluation and EKG screening: Every patient meets with a cardiologist before treatment. A baseline EKG checks the QT interval and rules out heart conditions that would make ibogaine unsafe.
• Bloodwork and electrolyte checks: A complete liver function test covers albumin, total protein, ALP, ALT, AST, GGT, and bilirubin. We also check vitamin and electrolyte levels, and correct low potassium or magnesium before dosing. A urinalysis screens for contraindicated drugs.
• Careful, individualized dosing: Your dose is based on weight, age, substances used, duration of use, liver function, heart function, bloodwork, and your response to a test dose. The dosing threshold is never pushed into dangerous territory.
• Magnesium support: Magnesium helps stabilize the heart’s electrical activity and is a standard treatment for torsades de pointes. Stanford researchers gave magnesium alongside ibogaine to protect the heart, and none of their 30 participants had a cardiac event.
• Continuous medical monitoring: Our medical staff provides 24/7 supervision, with cardiac monitoring during the dose and through the following days while noribogaine levels remain elevated.
• Safe preparation: Long-acting opioids such as methadone also prolong the QT interval, which is one reason patients switch to a short-acting opiate before treatment and fentanyl is flushed from the body first.

If screening shows that ibogaine isn’t safe for you, we’ll tell you plainly. We want this to be your decision, made with complete information. Ibogaine can also trigger vivid visions and emotional breakthroughs, which can be overwhelming for certain patients. Without proper support, you may struggle to process the treatment experience.

How to Get Started with Ibogaine Treatment?

Experience Ibogaine provides personalized ibogaine treatment to make this revolutionary treatment available to those who need it most. Our process includes pre-treatment preparation, assessing potential risks, comprehensive ibogaine treatment procedures, and post-treatment care. Our team provides an optimal treatment environment to prioritize your safety and comfort. Reach out to us today for more information.

Frequently Asked Questions (FAQs)

References

• Davis et al., Journal of Psychedelic Studies (2017)
• Noller et al., American Journal of Drug and Alcohol Abuse (2018)
• Stanford Medicine News Center (2024)
• iScience — Cell Press (2026)
• Cherian, Kristen N., et al. “Magnesium–ibogaine therapy in veterans with traumatic brain injuries.” Nature Medicine, January 5, 2024.
• Glue, P., et al. “Ascending single-dose, double-blind, placebo-controlled safety study of noribogaine in opioid-dependent patients.” Open Foundation, February 10, 2016.
• Koenig, Xaver, et al. “The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation.” MDPI, January 28, 2015.
• Noller, Geoffrey E., et al. “Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.” The American Journal of Drug and Alcohol Abuse, April 12, 2017.
• Ravven, Wallace. “Archive: Controversial drug shown to act on brain protein to cut alcohol use.” University of California San Francisco, January 18, 2005.
• Schenberg, Eduardo Ekman, et al. “Treating drug dependence with the aid of ibogaine: a retrospective study.” National Library of Medicine, September 29, 2014.